Evaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of Bradykinesia

NCT04385056 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
15
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

IMAC Holdings, Inc.